Modulation of cardiac mast cell-mediated extracellular matrix degradation by estrogen

Department of Anatomy, Physiology, and Pharmacology, Auburn University, Auburn, Alabama Submitted 28 July 2004 ; accepted in final form 14 February 2005 There are fundamental differences between males and females with regard to susceptibility to heart disease. Although numerous animal models of hear...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2005-07, Vol.289 (1), p.H316-H321
Hauptverfasser: Chancey, Amanda L, Gardner, Jason D, Murray, David B, Brower, Gregory L, Janicki, Joseph S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Department of Anatomy, Physiology, and Pharmacology, Auburn University, Auburn, Alabama Submitted 28 July 2004 ; accepted in final form 14 February 2005 There are fundamental differences between males and females with regard to susceptibility to heart disease. Although numerous animal models of heart failure have demonstrated that premenopausal females are afforded cardioprotection and, therefore, fare better in the face of cardiac disease than their male counterparts, many questions as to how this occurs still exist. Recently, we showed that 1 ) increased mast cell density is associated with adverse ventricular remodeling and 2 ) chemically induced mast cell degranulation using compound 48/80 resulted in remarkable changes in matrix metalloproteinase (MMP) activity, cardiac collagen structure, and cardiac diastolic function in normal male rats. With the known gender differences in cardiac disease in mind, we sought to examine the effects of chemically induced cardiac mast cell degranulation in isolated, blood-perfused hearts of intact female rats, ovariectomized female rats, and ovariectomized female rats treated with 17 -estradiol. In response to mast cell degranulation, no significant differences in cardiac function, MMP-2 activity, or collagen volume fraction were observed between intact female rats and ovariectomized female rats treated with estrogen. In the ovariectomized female group, a significant rightward shift in the left ventricular pressure-volume relation, accompanied by a marked 133% increase in active MMP-2 values over that in the intact female group, was noted after treatment with compound 48/80 ( P 0.05), along with a significant reduction in collagen volume fraction below control (0.46 ± 0.23 vs. 0.73 ± 0.13%, P 0.05). These findings indicate that estrogen's cardioprotective role can be partially mediated by its effects on cardiac mast cells, MMPs, and the extracellular matrix. isolated heart; matrix metalloproteinase; gender; ventricular remodeling Address for reprint requests and other correspondence: J. S. Janicki, Dept. of Cell and Developmental Biology, School of Medicine, University of South Carolina, Columbia, SC 29208
ISSN:0363-6135
1522-1539
DOI:10.1152/ajpheart.00765.2004